California Made a Big Bet on Producing Its Own Insulin, But There’s No ‘Date Certain’ for Delivery
During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...
infectiousdiseaseadvisor.com3d
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
pulmonologyadvisor5d
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
The US FDA has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes.
Benzinga.com14d
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Merilog is available in a 3 mL prefilled pen and a 10 mL vial, joining two long-acting insulin biosimilars approved ... biosimilar products to date. Like Novolog, Merilog should be administered ...
Daily14d
Sanofi's Merilog Receives USFDA Approval as Biosimilar to Novolog for Diabetes Management
New Delhi: Sanofi has received U.S. Food and Drug Administration (FDA) approval for Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for ... both a 3 mL single-patient-use ...
Medscape14d
FDA Okays New Rapid-Acting Biosimilar Insulin for Diabetes
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart ... patient-use prefilled pen and a 10 mL multiple-dose vial. Like Novolog, Merilog should be given ...
BioSpace14d
Sanofi Challenges Novo With First FDA Nod for NovoLog Biosimilar
Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for price caps and, potentially, the rise of the mammoth GLP-1 market.
Pharmabiz15d
US FDA approves Sanofi-Aventis’ rapid-acting insulin biosimilar product Merilog for improvement of glycaemic control in patients with diabetes
The US Food and Drug Administration (FDA) approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart ... single-patient-use prefilled pen and a 10 milliliter (mL) multiple-dose ...
The Pharma Letter15d
FDA nod for first rapid-acting insulin biosimilar
The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart), from Denmark’s Novo Nordisk, for the improvement of glycemic control in ...
Finanznachrichten15d
FDA Approves Merilog Rapid-Acting Insulin Biosimilar For Diabetes
Merilog has been approved as biosimilar to Novolog (insulin aspart ... single-patient-use prefilled pen and a 10 mL multiple-dose vial. As a rapid-acting human insulin, Merilog helps to lower ...
Sierra Sun Times15d
FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
February 17, 2025 - Last Friday, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin ... patient-use prefilled pen and a 10 milliliter ...